Methadone Dose and Retention During Treatment of Heroin Addicts with Axis I Psychiatric Comorbidity
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
We studied 90 opioid-dependent subjects, 38 with one or more additional Axis I diagnosis and 52 with no psychiatric comorbidity. There were significant differences between these two groups regarding the methadone dose required for clinical stabilization, but not in the rate of retention in treatment. Dual Diagnosis patients, those with psychiatric comorbidity, required an average stabilization dose of 154 +/- 84 of methadone compared to 99 +/- 49 mg/day for patients whose only Axis I diagnosis was Opioid Dependence. In the 990-day period considered there were no differences between the two groups of patients in terms of retention in treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While methadone has the most evidence of efficacy in comorbid BD and opioid use disorder (level 3),716, 717”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnosis and Symptoms of Depression in Opiate Addicts: Course and Relationship to Treatment Outcome
Rounsaville, B. J. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020021004 · Cited by 410
Untreated Opiate Addicts: How Do They Differ From Those Seeking Treatment?
Rounsaville, B. J. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790340050008 · Cited by 260
Suicide attempts in major affective disorder patients with comorbid substance use disorders.
Tondo, L., Baldessarini, R. J., Hennen, J. A., Minnai, G. P., Salis, P., Scamonatti, L., Masia, M., Ghiani, C., & Mannu, P. (1999) · PubMed · Cited by 237
Substance misuse and psychiatric comorbidity
Farrell, M., Howes, S., Taylor, C., Lewis, G., Jenkins, R., Bebbington, P., Jarvis, M., Brugha, T., Gill, B., & Meltzer, H. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00075-6 · Cited by 188
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.365 · Cited by 183
Strakowski, S. M., Sax, K. W., McElroy, S. L., Keck, P. E., Hawkins, J. M., & West, S. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0905 · Cited by 161
The relationship between substance abuse and bipolar disorder.
Brady, K. T., & Sonne, S. C. (1995) · PubMed · Cited by 154
Alcoholism and drug abuse in three groups — bipolar I, unipolars and their acquaintances
Winokur, G., Turvey, C., Akiskal, H. S., Coryell, W. H., Solomon, D. A., Leon, A. C., Mueller, T., Endicott, J., Maser, J. D., & Keller, M. B. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00108-6 · Cited by 147
Detecting depressive disorders in drug abusers
Rousaville, B. J., Weissman, M. M., Rosenberger, P. H., Wilber, C. H., & Kleber, H. D. (1979) · Journal of Affective Disorders · doi:10.1016/0165-0327(79)90012-0 · Cited by 87
Psychiatric Comorbidity in Methadone Maintained Patients
Mason, B. J., Kocsis, J. H., Melia, D., Khuri, E. T., Sweeney, J., Wells, A., Borg, L., Millman, R. B., Kreek, M. J., & Kreek, M. J. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n03_07 · Cited by 85
Opioids in mental illness: theories, clinical observations, and treatment possibilities.
Verebey, K. (1982) · PubMed · Cited by 65
Lin, C., Bai, Y. M., Hu, P. G., & Yeh, H. S. (1998) · General Hospital Psychiatry · doi:10.1016/s0163-8343(98)00003-6 · Cited by 37
A Comparison of the SADS/RDC and the DSM-III Diagnosing Drug Abusers
Rounsaville, B. J., Rosenberger, P. H., WILBER, C., et al. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198002000-00005 · Cited by 34
Pani, P. P., Trogu, E., Contu, P., Agus, A., & Gessa, G. L. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00115-4 · Cited by 30
Methadone Doses and Psychopathological Symptoms During Methadone Maintenance
Maremmani, I., Zolesi, O., Agueci, T., & Castrogiovanni, P. (1993) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1993.10472277 · Cited by 21
Self-citationPozzi, G., Bacigalupi, M., & Tempesta, E. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00042-2 · Cited by 18
Duffy, A. C., Grof, P., Grof, E., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00017-2 · Cited by 15
Mania secondary to alcohol binge.
Gupta, N., & Basu, D. (1997) · PubMed · Cited by 4
Research works printed but not linked: 8
- Brady K T, 1995, J Clin Psychia, 56, 19
- 1987, Diagnostic and Statistical Manual of Mental Disorders,
- Maremmani I., 1989, Ab.So.: Drug Addiction History Rating Scale
- Rounsaville B. J., 1985, Psychiatry
- Rounsaville B. J., 1985, Evaluating and Treating Depressive Disorders in Opiate Addicts
- Tondo L, 1999, J Clin Psychiatry, 60, 63
- Gupta N, 1997, Indian J Med Sci, 51, 394
- Hargreaves W., 1983, Research on the treatment of narcotic addiction, 19
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Anthony, I. C., Norrby, K. E., Dingwall, T., Carnie, F. W., Millar, T., Arango, J. C., Robertson, R., & Bell, J. E. (2010) · Brain · doi:10.1093/brain/awq263 · Cited by 156
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409722 · Cited by 141
“retention, reducing illicit opioid use, and reducing risk behavior [9,10,38,51,59]; dose titration usually takes more than 2 weeks, during which patients may remain vulnerable, using”
BackgroundSelf-citationBeaulieu, S., Saury, S., Sareen, J., Tremblay, J., Schütz, C. G., McIntyre, R. S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400105 · Cited by 38
Maremmani, A. G. I., Rovai, L., Bacciardi, S., Rugani, F., Pacini, M., Paolo Pani, P., Osso, L. D., Akiskal, H., & Maremmani, I. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.054 · Cited by 35
Self-citation
Metadata
- Authors
- Maremmani, I., Zolesi, O., Aglietti, M., Marini, G., Tagliamonte, A., Shinderman, M., & Maxwell, S.
- Affiliations
- University of Pisa (IT)
- University of Siena (IT)
- ORCID
- Maremmani, Icro
- Venue
- Journal of Addictive Diseases
- Publisher
- Informa UK Limited
- Published
- 2000-04-04
- Volume
- 19
- Issue
- 2
- Pages
- 29-41
- ISSN
- 1055-0887 (ISSN-L)
- 1545-0848
- OpenAlex
- W1500156157
- Cited by
- 74
- References
- 19
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 4 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 3 · 2013: 2 · 2012: 5
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Addictive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- methadone maintenance treatment, heroin addiction, opioid use disorder, psychiatric comorbidity, dual diagnosis, treatment retention, methadone dose, Axis I psychiatric disorders
- MeSH terms
- Adult, Mental Disorders, Female, Heroin Dependence, Humans, Male, Methadone, Patient Compliance, Psychiatric Status Rating Scales, Comorbidity, Treatment Outcome, Diagnosis, Dual (Psychiatry)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.